nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A1—Progesterone—uterine cancer	0.106	0.151	CbGbCtD
Rabeprazole—ABCG2—Dactinomycin—uterine cancer	0.0909	0.129	CbGbCtD
Rabeprazole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0643	0.0916	CbGbCtD
Rabeprazole—ABCG2—Carboplatin—uterine cancer	0.0611	0.087	CbGbCtD
Rabeprazole—ABCG2—Etoposide—uterine cancer	0.0513	0.073	CbGbCtD
Rabeprazole—CYP2C19—Progesterone—uterine cancer	0.0512	0.0729	CbGbCtD
Rabeprazole—CYP1A2—Progesterone—uterine cancer	0.0472	0.0673	CbGbCtD
Rabeprazole—CYP2C9—Progesterone—uterine cancer	0.0426	0.0606	CbGbCtD
Rabeprazole—CYP2D6—Progesterone—uterine cancer	0.0389	0.0555	CbGbCtD
Rabeprazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0374	0.0532	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—uterine cancer	0.035	0.0498	CbGbCtD
Rabeprazole—CYP3A4—Progesterone—uterine cancer	0.0248	0.0353	CbGbCtD
Rabeprazole—CYP1A2—Etoposide—uterine cancer	0.0211	0.0301	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—uterine cancer	0.0119	0.0169	CbGbCtD
Rabeprazole—CYP3A4—Etoposide—uterine cancer	0.0111	0.0158	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—uterine cancer	0.00756	0.0108	CbGbCtD
Rabeprazole—Omeprazole—CYP11A1—uterine cancer	0.00378	1	CrCbGaD
Rabeprazole—ATP4A—epithelium—uterine cancer	0.000978	0.118	CbGeAlD
Rabeprazole—ATP4A—renal system—uterine cancer	0.000907	0.11	CbGeAlD
Rabeprazole—ATP4A—female reproductive system—uterine cancer	0.000726	0.0879	CbGeAlD
Rabeprazole—ABCG2—myometrium—uterine cancer	0.000369	0.0447	CbGeAlD
Rabeprazole—ABCG2—uterine cervix—uterine cancer	0.000287	0.0348	CbGeAlD
Rabeprazole—CYP1A1—epithelium—uterine cancer	0.000275	0.0333	CbGeAlD
Rabeprazole—ABCG2—decidua—uterine cancer	0.000274	0.0331	CbGeAlD
Rabeprazole—CYP1A1—uterine cervix—uterine cancer	0.000273	0.033	CbGeAlD
Rabeprazole—ABCG2—endometrium—uterine cancer	0.00026	0.0315	CbGeAlD
Rabeprazole—CYP1A2—renal system—uterine cancer	0.000259	0.0313	CbGeAlD
Rabeprazole—CYP1A1—renal system—uterine cancer	0.000255	0.0309	CbGeAlD
Rabeprazole—ABCG2—mammalian vulva—uterine cancer	0.000251	0.0304	CbGeAlD
Rabeprazole—ABCG2—uterus—uterine cancer	0.000239	0.029	CbGeAlD
Rabeprazole—CYP1A1—mammalian vulva—uterine cancer	0.000239	0.0289	CbGeAlD
Rabeprazole—CYP2C19—vagina—uterine cancer	0.000229	0.0278	CbGeAlD
Rabeprazole—CYP1A1—uterus—uterine cancer	0.000227	0.0275	CbGeAlD
Rabeprazole—CYP1A1—female reproductive system—uterine cancer	0.000204	0.0247	CbGeAlD
Rabeprazole—CYP2C9—female reproductive system—uterine cancer	0.000197	0.0238	CbGeAlD
Rabeprazole—ABCG2—female gonad—uterine cancer	0.000196	0.0237	CbGeAlD
Rabeprazole—ABCG2—vagina—uterine cancer	0.000195	0.0236	CbGeAlD
Rabeprazole—CYP3A4—renal system—uterine cancer	0.000187	0.0227	CbGeAlD
Rabeprazole—CYP1A1—female gonad—uterine cancer	0.000186	0.0225	CbGeAlD
Rabeprazole—CYP1A1—vagina—uterine cancer	0.000185	0.0224	CbGeAlD
Rabeprazole—CYP2D6—renal system—uterine cancer	0.000184	0.0223	CbGeAlD
Rabeprazole—Hypokalaemia—Epirubicin—uterine cancer	0.000159	0.000564	CcSEcCtD
Rabeprazole—Discomfort—Etoposide—uterine cancer	0.000158	0.00056	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000157	0.000558	CcSEcCtD
Rabeprazole—Face oedema—Doxorubicin—uterine cancer	0.000156	0.000553	CcSEcCtD
Rabeprazole—Hypersensitivity—Dactinomycin—uterine cancer	0.000156	0.000553	CcSEcCtD
Rabeprazole—Gastritis—Epirubicin—uterine cancer	0.000155	0.000548	CcSEcCtD
Rabeprazole—Confusional state—Etoposide—uterine cancer	0.000155	0.000548	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000154	0.000546	CcSEcCtD
Rabeprazole—Anaphylactic shock—Etoposide—uterine cancer	0.000153	0.000543	CcSEcCtD
Rabeprazole—Abdominal distension—Epirubicin—uterine cancer	0.000152	0.000539	CcSEcCtD
Rabeprazole—Asthenia—Dactinomycin—uterine cancer	0.000152	0.000539	CcSEcCtD
Rabeprazole—Dysphagia—Epirubicin—uterine cancer	0.000151	0.000535	CcSEcCtD
Rabeprazole—Asthma—Epirubicin—uterine cancer	0.000151	0.000535	CcSEcCtD
Rabeprazole—Dehydration—Doxorubicin—uterine cancer	0.00015	0.000533	CcSEcCtD
Rabeprazole—Thrombocytopenia—Etoposide—uterine cancer	0.00015	0.000532	CcSEcCtD
Rabeprazole—CYP3A4—female reproductive system—uterine cancer	0.00015	0.0182	CbGeAlD
Rabeprazole—Tachycardia—Etoposide—uterine cancer	0.00015	0.00053	CcSEcCtD
Rabeprazole—Liver function test abnormal—Doxorubicin—uterine cancer	0.000149	0.000529	CcSEcCtD
Rabeprazole—Dry skin—Doxorubicin—uterine cancer	0.000148	0.000525	CcSEcCtD
Rabeprazole—Hyperhidrosis—Etoposide—uterine cancer	0.000148	0.000525	CcSEcCtD
Rabeprazole—Pancreatitis—Epirubicin—uterine cancer	0.000148	0.000525	CcSEcCtD
Rabeprazole—Abdominal pain upper—Doxorubicin—uterine cancer	0.000148	0.000524	CcSEcCtD
Rabeprazole—CYP2D6—female reproductive system—uterine cancer	0.000148	0.0179	CbGeAlD
Rabeprazole—Hypokalaemia—Doxorubicin—uterine cancer	0.000147	0.000522	CcSEcCtD
Rabeprazole—Angina pectoris—Epirubicin—uterine cancer	0.000147	0.000522	CcSEcCtD
Rabeprazole—Anorexia—Etoposide—uterine cancer	0.000146	0.000518	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000146	0.000516	CcSEcCtD
Rabeprazole—Bronchitis—Epirubicin—uterine cancer	0.000145	0.000515	CcSEcCtD
Rabeprazole—Diarrhoea—Dactinomycin—uterine cancer	0.000145	0.000514	CcSEcCtD
Rabeprazole—Pancytopenia—Epirubicin—uterine cancer	0.000144	0.000509	CcSEcCtD
Rabeprazole—Hypotension—Etoposide—uterine cancer	0.000143	0.000508	CcSEcCtD
Rabeprazole—Gastritis—Doxorubicin—uterine cancer	0.000143	0.000507	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000143	0.000506	CcSEcCtD
Rabeprazole—Dysuria—Epirubicin—uterine cancer	0.000141	0.000501	CcSEcCtD
Rabeprazole—Neutropenia—Epirubicin—uterine cancer	0.000141	0.000501	CcSEcCtD
Rabeprazole—Abdominal distension—Doxorubicin—uterine cancer	0.000141	0.000499	CcSEcCtD
Rabeprazole—Asthma—Doxorubicin—uterine cancer	0.00014	0.000495	CcSEcCtD
Rabeprazole—Dysphagia—Doxorubicin—uterine cancer	0.00014	0.000495	CcSEcCtD
Rabeprazole—Pollakiuria—Epirubicin—uterine cancer	0.00014	0.000495	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Epirubicin—uterine cancer	0.000138	0.000489	CcSEcCtD
Rabeprazole—Paraesthesia—Etoposide—uterine cancer	0.000138	0.000488	CcSEcCtD
Rabeprazole—Weight increased—Epirubicin—uterine cancer	0.000138	0.000487	CcSEcCtD
Rabeprazole—Pancreatitis—Doxorubicin—uterine cancer	0.000137	0.000486	CcSEcCtD
Rabeprazole—Weight decreased—Epirubicin—uterine cancer	0.000137	0.000484	CcSEcCtD
Rabeprazole—Dyspnoea—Etoposide—uterine cancer	0.000137	0.000484	CcSEcCtD
Rabeprazole—Hyperglycaemia—Epirubicin—uterine cancer	0.000136	0.000483	CcSEcCtD
Rabeprazole—Somnolence—Etoposide—uterine cancer	0.000136	0.000483	CcSEcCtD
Rabeprazole—Angina pectoris—Doxorubicin—uterine cancer	0.000136	0.000483	CcSEcCtD
Rabeprazole—Pneumonia—Epirubicin—uterine cancer	0.000136	0.00048	CcSEcCtD
Rabeprazole—Vomiting—Dactinomycin—uterine cancer	0.000135	0.000477	CcSEcCtD
Rabeprazole—Bronchitis—Doxorubicin—uterine cancer	0.000135	0.000476	CcSEcCtD
Rabeprazole—CYP2D6—female gonad—uterine cancer	0.000134	0.0163	CbGeAlD
Rabeprazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000134	0.000473	CcSEcCtD
Rabeprazole—Rash—Dactinomycin—uterine cancer	0.000134	0.000473	CcSEcCtD
Rabeprazole—Decreased appetite—Etoposide—uterine cancer	0.000133	0.000472	CcSEcCtD
Rabeprazole—Pancytopenia—Doxorubicin—uterine cancer	0.000133	0.000471	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Epirubicin—uterine cancer	0.000132	0.000468	CcSEcCtD
Rabeprazole—Jaundice—Epirubicin—uterine cancer	0.000131	0.000465	CcSEcCtD
Rabeprazole—Stomatitis—Epirubicin—uterine cancer	0.000131	0.000465	CcSEcCtD
Rabeprazole—Pain—Etoposide—uterine cancer	0.000131	0.000465	CcSEcCtD
Rabeprazole—Constipation—Etoposide—uterine cancer	0.000131	0.000465	CcSEcCtD
Rabeprazole—Conjunctivitis—Epirubicin—uterine cancer	0.000131	0.000464	CcSEcCtD
Rabeprazole—Urinary tract infection—Epirubicin—uterine cancer	0.000131	0.000464	CcSEcCtD
Rabeprazole—Dysuria—Doxorubicin—uterine cancer	0.000131	0.000463	CcSEcCtD
Rabeprazole—Neutropenia—Doxorubicin—uterine cancer	0.000131	0.000463	CcSEcCtD
Rabeprazole—Sweating—Epirubicin—uterine cancer	0.000129	0.000458	CcSEcCtD
Rabeprazole—Pollakiuria—Doxorubicin—uterine cancer	0.000129	0.000458	CcSEcCtD
Rabeprazole—Haematuria—Epirubicin—uterine cancer	0.000129	0.000455	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000128	0.000452	CcSEcCtD
Rabeprazole—Weight increased—Doxorubicin—uterine cancer	0.000127	0.000451	CcSEcCtD
Rabeprazole—Epistaxis—Epirubicin—uterine cancer	0.000127	0.00045	CcSEcCtD
Rabeprazole—Weight decreased—Doxorubicin—uterine cancer	0.000127	0.000448	CcSEcCtD
Rabeprazole—Sinusitis—Epirubicin—uterine cancer	0.000126	0.000448	CcSEcCtD
Rabeprazole—Feeling abnormal—Etoposide—uterine cancer	0.000126	0.000448	CcSEcCtD
Rabeprazole—Hyperglycaemia—Doxorubicin—uterine cancer	0.000126	0.000447	CcSEcCtD
Rabeprazole—ABCG2—lymph node—uterine cancer	0.000126	0.0152	CbGeAlD
Rabeprazole—Nausea—Dactinomycin—uterine cancer	0.000126	0.000446	CcSEcCtD
Rabeprazole—Agranulocytosis—Epirubicin—uterine cancer	0.000126	0.000446	CcSEcCtD
Rabeprazole—Pneumonia—Doxorubicin—uterine cancer	0.000125	0.000444	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Etoposide—uterine cancer	0.000125	0.000444	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000124	0.000438	CcSEcCtD
Rabeprazole—Bradycardia—Epirubicin—uterine cancer	0.000123	0.000436	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000122	0.000433	CcSEcCtD
Rabeprazole—Urticaria—Etoposide—uterine cancer	0.000122	0.000432	CcSEcCtD
Rabeprazole—Jaundice—Doxorubicin—uterine cancer	0.000122	0.000431	CcSEcCtD
Rabeprazole—Stomatitis—Doxorubicin—uterine cancer	0.000122	0.000431	CcSEcCtD
Rabeprazole—Rhinitis—Epirubicin—uterine cancer	0.000121	0.00043	CcSEcCtD
Rabeprazole—Abdominal pain—Etoposide—uterine cancer	0.000121	0.000429	CcSEcCtD
Rabeprazole—Body temperature increased—Etoposide—uterine cancer	0.000121	0.000429	CcSEcCtD
Rabeprazole—Urinary tract infection—Doxorubicin—uterine cancer	0.000121	0.000429	CcSEcCtD
Rabeprazole—Conjunctivitis—Doxorubicin—uterine cancer	0.000121	0.000429	CcSEcCtD
Rabeprazole—Hepatitis—Epirubicin—uterine cancer	0.000121	0.000429	CcSEcCtD
Rabeprazole—Pharyngitis—Epirubicin—uterine cancer	0.00012	0.000425	CcSEcCtD
Rabeprazole—CYP1A1—lymph node—uterine cancer	0.00012	0.0145	CbGeAlD
Rabeprazole—Sweating—Doxorubicin—uterine cancer	0.00012	0.000424	CcSEcCtD
Rabeprazole—Urinary tract disorder—Epirubicin—uterine cancer	0.000119	0.000423	CcSEcCtD
Rabeprazole—Oedema peripheral—Epirubicin—uterine cancer	0.000119	0.000422	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—uterine cancer	0.000119	0.000421	CcSEcCtD
Rabeprazole—Urethral disorder—Epirubicin—uterine cancer	0.000119	0.00042	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—uterine cancer	0.000118	0.000417	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—uterine cancer	0.000117	0.000414	CcSEcCtD
Rabeprazole—Visual impairment—Epirubicin—uterine cancer	0.000117	0.000413	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—uterine cancer	0.000116	0.000412	CcSEcCtD
Rabeprazole—Erythema multiforme—Epirubicin—uterine cancer	0.000114	0.000405	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—uterine cancer	0.000114	0.000404	CcSEcCtD
Rabeprazole—Eye disorder—Epirubicin—uterine cancer	0.000113	0.000401	CcSEcCtD
Rabeprazole—Hypersensitivity—Etoposide—uterine cancer	0.000113	0.0004	CcSEcCtD
Rabeprazole—Tinnitus—Epirubicin—uterine cancer	0.000113	0.0004	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—uterine cancer	0.000112	0.000398	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—uterine cancer	0.000112	0.000397	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—uterine cancer	0.000111	0.000394	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—uterine cancer	0.000111	0.000392	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—uterine cancer	0.00011	0.000391	CcSEcCtD
Rabeprazole—Asthenia—Etoposide—uterine cancer	0.00011	0.00039	CcSEcCtD
Rabeprazole—Angiopathy—Epirubicin—uterine cancer	0.00011	0.000389	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—uterine cancer	0.00011	0.000389	CcSEcCtD
Rabeprazole—Chills—Epirubicin—uterine cancer	0.000109	0.000385	CcSEcCtD
Rabeprazole—Pruritus—Etoposide—uterine cancer	0.000108	0.000384	CcSEcCtD
Rabeprazole—Arrhythmia—Epirubicin—uterine cancer	0.000108	0.000383	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—uterine cancer	0.000108	0.000382	CcSEcCtD
Rabeprazole—Alopecia—Epirubicin—uterine cancer	0.000107	0.000379	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—uterine cancer	0.000106	0.000375	CcSEcCtD
Rabeprazole—Malnutrition—Epirubicin—uterine cancer	0.000105	0.000373	CcSEcCtD
Rabeprazole—Erythema—Epirubicin—uterine cancer	0.000105	0.000373	CcSEcCtD
Rabeprazole—Diarrhoea—Etoposide—uterine cancer	0.000105	0.000372	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—uterine cancer	0.000105	0.000371	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—uterine cancer	0.000104	0.00037	CcSEcCtD
Rabeprazole—Flatulence—Epirubicin—uterine cancer	0.000104	0.000368	CcSEcCtD
Rabeprazole—Tension—Epirubicin—uterine cancer	0.000103	0.000366	CcSEcCtD
Rabeprazole—Dysgeusia—Epirubicin—uterine cancer	0.000103	0.000365	CcSEcCtD
Rabeprazole—Nervousness—Epirubicin—uterine cancer	0.000102	0.000362	CcSEcCtD
Rabeprazole—Back pain—Epirubicin—uterine cancer	0.000102	0.000361	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—uterine cancer	0.000102	0.00036	CcSEcCtD
Rabeprazole—Dizziness—Etoposide—uterine cancer	0.000101	0.000359	CcSEcCtD
Rabeprazole—Muscle spasms—Epirubicin—uterine cancer	0.000101	0.000359	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—uterine cancer	0.0001	0.000356	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—uterine cancer	0.0001	0.000354	CcSEcCtD
Rabeprazole—Vision blurred—Epirubicin—uterine cancer	9.93e-05	0.000352	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—uterine cancer	9.89e-05	0.00035	CcSEcCtD
Rabeprazole—Ill-defined disorder—Epirubicin—uterine cancer	9.77e-05	0.000346	CcSEcCtD
Rabeprazole—Vomiting—Etoposide—uterine cancer	9.75e-05	0.000345	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—uterine cancer	9.75e-05	0.000345	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—uterine cancer	9.75e-05	0.000345	CcSEcCtD
Rabeprazole—Anaemia—Epirubicin—uterine cancer	9.73e-05	0.000345	CcSEcCtD
Rabeprazole—Agitation—Epirubicin—uterine cancer	9.68e-05	0.000343	CcSEcCtD
Rabeprazole—Rash—Etoposide—uterine cancer	9.67e-05	0.000343	CcSEcCtD
Rabeprazole—Dermatitis—Etoposide—uterine cancer	9.66e-05	0.000342	CcSEcCtD
Rabeprazole—Headache—Etoposide—uterine cancer	9.61e-05	0.00034	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—uterine cancer	9.6e-05	0.00034	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—uterine cancer	9.56e-05	0.000339	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—uterine cancer	9.54e-05	0.000338	CcSEcCtD
Rabeprazole—Malaise—Epirubicin—uterine cancer	9.5e-05	0.000336	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—uterine cancer	9.47e-05	0.000335	CcSEcCtD
Rabeprazole—Vertigo—Epirubicin—uterine cancer	9.46e-05	0.000335	CcSEcCtD
Rabeprazole—Syncope—Epirubicin—uterine cancer	9.45e-05	0.000335	CcSEcCtD
Rabeprazole—Leukopenia—Epirubicin—uterine cancer	9.43e-05	0.000334	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—uterine cancer	9.43e-05	0.000334	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—uterine cancer	9.37e-05	0.000332	CcSEcCtD
Rabeprazole—Palpitations—Epirubicin—uterine cancer	9.31e-05	0.00033	CcSEcCtD
Rabeprazole—Loss of consciousness—Epirubicin—uterine cancer	9.26e-05	0.000328	CcSEcCtD
Rabeprazole—Cough—Epirubicin—uterine cancer	9.19e-05	0.000326	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—uterine cancer	9.18e-05	0.000325	CcSEcCtD
Rabeprazole—Convulsion—Epirubicin—uterine cancer	9.13e-05	0.000323	CcSEcCtD
Rabeprazole—Nausea—Etoposide—uterine cancer	9.11e-05	0.000323	CcSEcCtD
Rabeprazole—Hypertension—Epirubicin—uterine cancer	9.09e-05	0.000322	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—uterine cancer	9.04e-05	0.00032	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—uterine cancer	9.01e-05	0.000319	CcSEcCtD
Rabeprazole—Myalgia—Epirubicin—uterine cancer	8.97e-05	0.000318	CcSEcCtD
Rabeprazole—Arthralgia—Epirubicin—uterine cancer	8.97e-05	0.000318	CcSEcCtD
Rabeprazole—Chest pain—Epirubicin—uterine cancer	8.97e-05	0.000318	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—uterine cancer	8.96e-05	0.000317	CcSEcCtD
Rabeprazole—Anxiety—Epirubicin—uterine cancer	8.94e-05	0.000317	CcSEcCtD
Rabeprazole—Discomfort—Epirubicin—uterine cancer	8.86e-05	0.000314	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—uterine cancer	8.79e-05	0.000311	CcSEcCtD
Rabeprazole—Dry mouth—Epirubicin—uterine cancer	8.77e-05	0.000311	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—uterine cancer	8.76e-05	0.00031	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—uterine cancer	8.74e-05	0.00031	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—uterine cancer	8.72e-05	0.000309	CcSEcCtD
Rabeprazole—Confusional state—Epirubicin—uterine cancer	8.67e-05	0.000307	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—uterine cancer	8.61e-05	0.000305	CcSEcCtD
Rabeprazole—Anaphylactic shock—Epirubicin—uterine cancer	8.6e-05	0.000305	CcSEcCtD
Rabeprazole—Oedema—Epirubicin—uterine cancer	8.6e-05	0.000305	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—uterine cancer	8.57e-05	0.000303	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—uterine cancer	8.5e-05	0.000301	CcSEcCtD
Rabeprazole—Shock—Epirubicin—uterine cancer	8.46e-05	0.0003	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—uterine cancer	8.44e-05	0.000299	CcSEcCtD
Rabeprazole—Thrombocytopenia—Epirubicin—uterine cancer	8.42e-05	0.000298	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—uterine cancer	8.41e-05	0.000298	CcSEcCtD
Rabeprazole—Tachycardia—Epirubicin—uterine cancer	8.39e-05	0.000297	CcSEcCtD
Rabeprazole—Hyperhidrosis—Epirubicin—uterine cancer	8.31e-05	0.000294	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—uterine cancer	8.3e-05	0.000294	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—uterine cancer	8.3e-05	0.000294	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—uterine cancer	8.3e-05	0.000294	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—uterine cancer	8.27e-05	0.000293	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—uterine cancer	8.2e-05	0.00029	CcSEcCtD
Rabeprazole—Anorexia—Epirubicin—uterine cancer	8.19e-05	0.00029	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—uterine cancer	8.11e-05	0.000287	CcSEcCtD
Rabeprazole—Hypotension—Epirubicin—uterine cancer	8.03e-05	0.000285	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—uterine cancer	8.02e-05	0.000284	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—uterine cancer	7.95e-05	0.000282	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—uterine cancer	7.95e-05	0.000282	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	7.83e-05	0.000277	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—uterine cancer	7.82e-05	0.000277	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—uterine cancer	7.79e-05	0.000276	CcSEcCtD
Rabeprazole—Insomnia—Epirubicin—uterine cancer	7.77e-05	0.000275	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—uterine cancer	7.76e-05	0.000275	CcSEcCtD
Rabeprazole—Paraesthesia—Epirubicin—uterine cancer	7.72e-05	0.000273	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—uterine cancer	7.69e-05	0.000272	CcSEcCtD
Rabeprazole—Dyspnoea—Epirubicin—uterine cancer	7.66e-05	0.000271	CcSEcCtD
Rabeprazole—Somnolence—Epirubicin—uterine cancer	7.64e-05	0.000271	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—uterine cancer	7.58e-05	0.000269	CcSEcCtD
Rabeprazole—Dyspepsia—Epirubicin—uterine cancer	7.57e-05	0.000268	CcSEcCtD
Rabeprazole—Decreased appetite—Epirubicin—uterine cancer	7.47e-05	0.000265	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—uterine cancer	7.43e-05	0.000263	CcSEcCtD
Rabeprazole—Pain—Epirubicin—uterine cancer	7.35e-05	0.00026	CcSEcCtD
Rabeprazole—Constipation—Epirubicin—uterine cancer	7.35e-05	0.00026	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	7.25e-05	0.000257	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—uterine cancer	7.19e-05	0.000255	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—uterine cancer	7.14e-05	0.000253	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—uterine cancer	7.09e-05	0.000251	CcSEcCtD
Rabeprazole—Feeling abnormal—Epirubicin—uterine cancer	7.08e-05	0.000251	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—uterine cancer	7.07e-05	0.00025	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Epirubicin—uterine cancer	7.03e-05	0.000249	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—uterine cancer	7e-05	0.000248	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—uterine cancer	6.91e-05	0.000245	CcSEcCtD
Rabeprazole—Urticaria—Epirubicin—uterine cancer	6.83e-05	0.000242	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—uterine cancer	6.8e-05	0.000241	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—uterine cancer	6.8e-05	0.000241	CcSEcCtD
Rabeprazole—Body temperature increased—Epirubicin—uterine cancer	6.8e-05	0.000241	CcSEcCtD
Rabeprazole—Abdominal pain—Epirubicin—uterine cancer	6.8e-05	0.000241	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—uterine cancer	6.55e-05	0.000232	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—uterine cancer	6.5e-05	0.00023	CcSEcCtD
Rabeprazole—Hypersensitivity—Epirubicin—uterine cancer	6.33e-05	0.000224	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—uterine cancer	6.32e-05	0.000224	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—uterine cancer	6.29e-05	0.000223	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—uterine cancer	6.29e-05	0.000223	CcSEcCtD
Rabeprazole—Asthenia—Epirubicin—uterine cancer	6.17e-05	0.000218	CcSEcCtD
Rabeprazole—Pruritus—Epirubicin—uterine cancer	6.08e-05	0.000215	CcSEcCtD
Rabeprazole—Diarrhoea—Epirubicin—uterine cancer	5.88e-05	0.000208	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—uterine cancer	5.86e-05	0.000208	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—uterine cancer	5.71e-05	0.000202	CcSEcCtD
Rabeprazole—Dizziness—Epirubicin—uterine cancer	5.68e-05	0.000201	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—uterine cancer	5.63e-05	0.000199	CcSEcCtD
Rabeprazole—Vomiting—Epirubicin—uterine cancer	5.47e-05	0.000194	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—uterine cancer	5.44e-05	0.000193	CcSEcCtD
Rabeprazole—Rash—Epirubicin—uterine cancer	5.42e-05	0.000192	CcSEcCtD
Rabeprazole—Dermatitis—Epirubicin—uterine cancer	5.41e-05	0.000192	CcSEcCtD
Rabeprazole—Headache—Epirubicin—uterine cancer	5.38e-05	0.000191	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—uterine cancer	5.26e-05	0.000186	CcSEcCtD
Rabeprazole—Nausea—Epirubicin—uterine cancer	5.11e-05	0.000181	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—uterine cancer	5.06e-05	0.000179	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—uterine cancer	5.01e-05	0.000178	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—uterine cancer	5.01e-05	0.000177	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—uterine cancer	4.98e-05	0.000177	CcSEcCtD
Rabeprazole—Nausea—Doxorubicin—uterine cancer	4.72e-05	0.000167	CcSEcCtD
Rabeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.99e-05	0.00535	CbGpPWpGaD
Rabeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.97e-05	0.0053	CbGpPWpGaD
Rabeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.96e-05	0.00528	CbGpPWpGaD
Rabeprazole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.95e-05	0.00523	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	1.92e-05	0.00516	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	1.9e-05	0.00512	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—AKR1C1—uterine cancer	1.87e-05	0.00503	CbGpPWpGaD
Rabeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.86e-05	0.00499	CbGpPWpGaD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—TP53—uterine cancer	1.8e-05	0.00483	CbGpPWpGaD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	1.77e-05	0.00475	CbGpPWpGaD
Rabeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.75e-05	0.00471	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	1.75e-05	0.0047	CbGpPWpGaD
Rabeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	1.74e-05	0.00469	CbGpPWpGaD
Rabeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.68e-05	0.00453	CbGpPWpGaD
Rabeprazole—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.66e-05	0.00447	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—GPX3—uterine cancer	1.64e-05	0.00442	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	1.63e-05	0.00437	CbGpPWpGaD
Rabeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.61e-05	0.00434	CbGpPWpGaD
Rabeprazole—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	1.61e-05	0.00432	CbGpPWpGaD
Rabeprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.6e-05	0.0043	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—CYP11A1—uterine cancer	1.55e-05	0.00416	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	1.53e-05	0.00412	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—CYP11A1—uterine cancer	1.53e-05	0.0041	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	1.48e-05	0.00399	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	1.48e-05	0.00399	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—EP300—uterine cancer	1.44e-05	0.00388	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—AKR1C3—uterine cancer	1.44e-05	0.00387	CbGpPWpGaD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.43e-05	0.00385	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	1.41e-05	0.00379	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	1.4e-05	0.00375	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.39e-05	0.00375	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	1.39e-05	0.00374	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.37e-05	0.00369	CbGpPWpGaD
Rabeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.37e-05	0.00367	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.37e-05	0.00367	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	1.35e-05	0.00363	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	1.34e-05	0.00362	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	1.3e-05	0.0035	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	1.3e-05	0.0035	CbGpPWpGaD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.3e-05	0.0035	CbGpPWpGaD
Rabeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.28e-05	0.00345	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	1.27e-05	0.0034	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	1.25e-05	0.00337	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	1.25e-05	0.00336	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	1.24e-05	0.00332	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	1.23e-05	0.00332	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	1.23e-05	0.0033	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	1.22e-05	0.00328	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	1.19e-05	0.00321	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	1.18e-05	0.00317	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	1.16e-05	0.00313	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	1.15e-05	0.0031	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	1.15e-05	0.00309	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	1.14e-05	0.00306	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—CYP19A1—uterine cancer	1.14e-05	0.00306	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.12e-05	0.00302	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—CYP19A1—uterine cancer	1.12e-05	0.00302	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	1.08e-05	0.00292	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	1.07e-05	0.00289	CbGpPWpGaD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.05e-05	0.00283	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	1.05e-05	0.00282	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	1.05e-05	0.00282	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.02e-05	0.00275	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9.92e-06	0.00267	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9.92e-06	0.00267	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	9.86e-06	0.00265	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	9.72e-06	0.00262	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	9.46e-06	0.00254	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	9.46e-06	0.00254	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	9.31e-06	0.0025	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	9.21e-06	0.00248	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	9.18e-06	0.00247	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	9.18e-06	0.00247	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SRD5A2—uterine cancer	9.03e-06	0.00243	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NDUFB11—uterine cancer	9.03e-06	0.00243	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	8.92e-06	0.0024	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.75e-06	0.00235	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	8.71e-06	0.00234	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	8.56e-06	0.0023	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	8.49e-06	0.00228	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	8.45e-06	0.00227	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	8.37e-06	0.00225	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	8.31e-06	0.00223	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	8.31e-06	0.00223	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.12e-06	0.00218	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.12e-06	0.00218	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	8.08e-06	0.00217	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	7.87e-06	0.00212	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	7.77e-06	0.00209	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	7.61e-06	0.00205	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	7.51e-06	0.00202	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.41e-06	0.00199	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.41e-06	0.00199	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.28e-06	0.00196	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	7.25e-06	0.00195	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	7.15e-06	0.00192	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	7.09e-06	0.00191	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	6.69e-06	0.0018	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—STAR—uterine cancer	6.53e-06	0.00176	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKR1B1—uterine cancer	6.53e-06	0.00176	CbGpPWpGaD
Rabeprazole—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	6.49e-06	0.00174	CbGpPWpGaD
Rabeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	6.35e-06	0.00171	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.33e-06	0.0017	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.33e-06	0.0017	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NDUFB11—uterine cancer	6.11e-06	0.00164	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SRD5A2—uterine cancer	6.11e-06	0.00164	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.96e-06	0.0016	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.94e-06	0.0016	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	5.69e-06	0.00153	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.61e-06	0.00151	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	5.6e-06	0.00151	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	5.52e-06	0.00149	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.44e-06	0.00146	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—POLD1—uterine cancer	5.12e-06	0.00138	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NDUFB11—uterine cancer	5e-06	0.00135	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SRD5A2—uterine cancer	5e-06	0.00135	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.86e-06	0.00131	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKR1C1—uterine cancer	4.79e-06	0.00129	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.64e-06	0.00125	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SRD5A2—uterine cancer	4.6e-06	0.00124	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NDUFB11—uterine cancer	4.6e-06	0.00124	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.59e-06	0.00123	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NDUFB11—uterine cancer	4.56e-06	0.00123	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SRD5A2—uterine cancer	4.56e-06	0.00123	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.43e-06	0.00119	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKR1B1—uterine cancer	4.42e-06	0.00119	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—STAR—uterine cancer	4.42e-06	0.00119	CbGpPWpGaD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	4.37e-06	0.00118	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.37e-06	0.00117	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—RRM2—uterine cancer	4.27e-06	0.00115	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.18e-06	0.00113	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—DCN—uterine cancer	4.15e-06	0.00112	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP11A1—uterine cancer	3.91e-06	0.00105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NDUFB11—uterine cancer	3.9e-06	0.00105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SRD5A2—uterine cancer	3.9e-06	0.00105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.79e-06	0.00102	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKR1C3—uterine cancer	3.69e-06	0.000992	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKR1B1—uterine cancer	3.62e-06	0.000973	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—STAR—uterine cancer	3.62e-06	0.000973	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.58e-06	0.000962	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.58e-06	0.000962	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—POLD1—uterine cancer	3.47e-06	0.000933	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKR1B1—uterine cancer	3.33e-06	0.000895	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—STAR—uterine cancer	3.33e-06	0.000895	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.3e-06	0.000887	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—STAR—uterine cancer	3.3e-06	0.000887	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.26e-06	0.000877	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKR1C1—uterine cancer	3.24e-06	0.000872	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.01e-06	0.000809	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.01e-06	0.000809	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—RRM2—uterine cancer	2.89e-06	0.000778	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—STK11—uterine cancer	2.87e-06	0.000773	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP19A1—uterine cancer	2.87e-06	0.000773	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—POLD1—uterine cancer	2.84e-06	0.000763	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.82e-06	0.000758	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—STAR—uterine cancer	2.82e-06	0.000758	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—DCN—uterine cancer	2.81e-06	0.000755	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.79e-06	0.000749	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.65e-06	0.000714	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP11A1—uterine cancer	2.64e-06	0.000711	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—POLD1—uterine cancer	2.61e-06	0.000702	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—POLD1—uterine cancer	2.59e-06	0.000696	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKR1C3—uterine cancer	2.5e-06	0.000672	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.44e-06	0.000657	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.42e-06	0.000651	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—RRM2—uterine cancer	2.37e-06	0.000636	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—DCN—uterine cancer	2.3e-06	0.000618	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—POLD1—uterine cancer	2.21e-06	0.000595	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—RRM2—uterine cancer	2.18e-06	0.000585	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.18e-06	0.000585	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—STAR—uterine cancer	2.18e-06	0.000585	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.16e-06	0.000582	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—MTHFR—uterine cancer	2.16e-06	0.000581	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—RRM2—uterine cancer	2.16e-06	0.00058	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—DCN—uterine cancer	2.11e-06	0.000568	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—DCN—uterine cancer	2.09e-06	0.000563	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.07e-06	0.000556	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.04e-06	0.00055	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.99e-06	0.000535	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.97e-06	0.000531	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—STK11—uterine cancer	1.95e-06	0.000523	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.95e-06	0.000523	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.88e-06	0.000506	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.86e-06	0.000501	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—RRM2—uterine cancer	1.84e-06	0.000496	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.83e-06	0.000491	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—DCN—uterine cancer	1.79e-06	0.000481	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.74e-06	0.000468	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—POLD1—uterine cancer	1.71e-06	0.000459	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.69e-06	0.000454	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.6e-06	0.000429	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.59e-06	0.000428	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—STK11—uterine cancer	1.59e-06	0.000428	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.59e-06	0.000428	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.49e-06	0.000402	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—STK11—uterine cancer	1.46e-06	0.000394	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.46e-06	0.000394	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MTHFR—uterine cancer	1.46e-06	0.000393	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.45e-06	0.00039	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—STK11—uterine cancer	1.45e-06	0.00039	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.43e-06	0.000383	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—RRM2—uterine cancer	1.42e-06	0.000383	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—DCN—uterine cancer	1.38e-06	0.000371	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.36e-06	0.000367	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.3e-06	0.00035	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.3e-06	0.00035	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.29e-06	0.000347	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—STK11—uterine cancer	1.24e-06	0.000334	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.24e-06	0.000334	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.23e-06	0.000331	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—uterine cancer	1.2e-06	0.000323	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTHFR—uterine cancer	1.2e-06	0.000322	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.16e-06	0.000313	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—EP300—uterine cancer	1.15e-06	0.000308	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.11e-06	0.000299	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTHFR—uterine cancer	1.1e-06	0.000296	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTHFR—uterine cancer	1.09e-06	0.000293	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.05e-06	0.000284	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.61e-07	0.000259	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—STK11—uterine cancer	9.57e-07	0.000258	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP19A1—uterine cancer	9.57e-07	0.000258	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTHFR—uterine cancer	9.32e-07	0.000251	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—uterine cancer	8.48e-07	0.000228	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.22e-07	0.000221	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—uterine cancer	8.13e-07	0.000219	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—EP300—uterine cancer	7.76e-07	0.000209	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTHFR—uterine cancer	7.19e-07	0.000194	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—uterine cancer	6.93e-07	0.000186	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—uterine cancer	6.66e-07	0.000179	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—EP300—uterine cancer	6.35e-07	0.000171	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—uterine cancer	6.12e-07	0.000165	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—uterine cancer	6.07e-07	0.000163	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—EP300—uterine cancer	5.84e-07	0.000157	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—EP300—uterine cancer	5.79e-07	0.000156	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—uterine cancer	5.74e-07	0.000154	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—uterine cancer	5.19e-07	0.000139	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—EP300—uterine cancer	4.95e-07	0.000133	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—uterine cancer	4.7e-07	0.000126	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—uterine cancer	4.69e-07	0.000126	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.32e-07	0.000116	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.28e-07	0.000115	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—uterine cancer	4e-07	0.000108	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—uterine cancer	3.84e-07	0.000103	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—EP300—uterine cancer	3.82e-07	0.000103	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—uterine cancer	3.66e-07	9.84e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—uterine cancer	3.53e-07	9.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—uterine cancer	3.5e-07	9.41e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—uterine cancer	2.99e-07	8.04e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.82e-07	7.59e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—uterine cancer	2.31e-07	6.2e-05	CbGpPWpGaD
